Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atripla and Pravastatin in HIV-infected individuals with high CD4 counts
NCT01515813Phase 2Withdrawn
- Start
- Nov 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pravastatin, tenofovir disoproxil fumarate in human immunodeficiency virus type 1 infection (HIV-1), cardiovascular disease (CVD). Planned start Nov 2011; status: withdrawn.
02
Drugs
pravastatintenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01515813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01515813.